iCon Group Ltd (TLV:ICON)

Marinus Pharmaceuticals Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10.26	10.32	11.42	7.07	28.28	4.81
Cash & Short-Term Investments	10.26	10.32	11.42	7.07	28.28	4.81
Cash Growth	-43.75%	-9.68%	61.54%	-75.00%	488.27%	-51.82%
Accounts Receivable	311.37	378.5	289.66	270.93	204.5	150.73
Other Receivables	21.51	58.03	24.23	17.16	12.89	17.43
Receivables	332.88	436.53	313.89	288.09	217.39	168.15
Inventory	180.97	241.78	104.8	174.41	177.02	106.89
Prepaid Expenses	-	0.87	1.63	2.39	1.34	0.53
Other Current Assets	-	2.14	1.73	3.36	2.91	0.9
Total Current Assets	524.11	691.63	433.47	475.32	426.95	281.27
Property, Plant & Equipment	101.64	107.24	90.03	97.93	92.02	49.69
Long-Term Investments	20.47	19.4	19.28	21.7	-	-
Goodwill	-	17.74	17.74	13.43	-	-
Other Intangible Assets	21.61	4.01	4.57	5.13	-	-
Long-Term Deferred Tax Assets	3.27	3.28	2.87	2.93	2.04	1.16
Other Long-Term Assets	0.43	0.45	0.69	3.1	3.17	0.18
Total Assets	671.52	843.75	568.64	619.52	524.17	332.29
Accounts Payable	97.36	228.49	142.63	139.15	206.38	150.32
Accrued Expenses	-	18.06	20.81	23.09	28.29	21.13
Short-Term Debt	165.3	194.54	49.41	115.61	0.02	14.2
Current Portion of Leases	14.9	15.39	15.98	15.66	14.38	7.59
Current Unearned Revenue	9.49	7.47	5.99	5.44	14.61	18.74
Other Current Liabilities	30.61	27.39	26.43	18.37	9.51	8.69
Total Current Liabilities	317.65	491.34	261.26	317.31	273.18	220.66
Long-Term Debt	-	-	-	0.69	-	-
Long-Term Leases	77.39	80.82	61.84	70.18	65.59	31.75
Long-Term Unearned Revenue	7.14	8.69	3.42	2.33	2.37	1.67
Other Long-Term Liabilities	0.17	0.16	0.21	11.93	0.35	0.38
Total Liabilities	402.35	581.02	326.73	402.44	341.48	254.47
Additional Paid-In Capital	93.98	93.94	93.33	92	89.23	14.43
Retained Earnings	175.19	168.79	148.59	125.7	93.33	63.27
Treasury Stock	-	-	-	-1.71	-	-
Comprehensive Income & Other	-	-	-	0.13	0.13	0.13
Total Common Equity	269.17	262.73	241.91	216.11	182.69	77.83
Minority Interest	-	-	-	0.97	-	-
Shareholders' Equity	269.17	262.73	241.91	217.08	182.69	77.83
Total Liabilities & Equity	671.52	843.75	568.64	619.52	524.17	332.29
Total Debt	257.58	290.74	127.23	202.13	79.99	53.54
Net Cash (Debt)	-247.33	-280.43	-115.81	-195.06	-51.7	-48.73
Net Cash Per Share	-4.29	-4.89	-2.04	-3.37	-0.89	-0.96
Filing Date Shares Outstanding	55.89	57.12	56.07	56.45	55.86	50.9
Total Common Shares Outstanding	55.89	57.12	56.07	56.45	55.86	50.9
Working Capital	206.46	200.29	172.22	158.01	153.77	60.61
Book Value Per Share	4.82	4.60	4.31	3.77	3.27	1.53
Tangible Book Value	247.56	240.98	219.6	197.56	182.69	77.83
Tangible Book Value Per Share	4.43	4.22	3.92	3.45	3.27	1.53
Machinery	-	27.97	27.51	24.38	22.03	20.31
Leasehold Improvements	-	25.86	23.38	22.28	19.63	16

Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.